CD4 and cancer: CD3+, CD4+, and CD20+ lymphocytes were expressed in all three prostate regions examined in the study—benign biopsy (BBG), tumor‐adjacent normal glands (TAG), and malignant tumor glands (MTG) (Figure S1).